Defibrillator Market By Product Type (Implantable Cardioverter Defibrillators{Single-chamber ICDs, Dual-chamber ICDs, Subcutaneous ICDs},External Defibrillators{Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators}), By Application (Sudden Cardiac Arrest, Arrhythmia Management, Congestive Heart Failure), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Sales), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, Public Access Settings, Emergency Medical Services), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Defibrillator Market accounted for USD 8.16 Billion in 2024 and is expected to reach USD 19.42 Billion by 2035, growing at a CAGR of around 8.2% between 2025 and 2035. A defibrillator is a device applied to deliver electric impulses to the heart volume in situations when the heart requires rebooting, such as in cases of SCA or arrhythmia.

It does this by placing a controlled electric shock on the heart to help it regain its normal rhythm to the normal electricity. Defibrillators can be considered outside the body, like AEDs, and internal, like ICDs that are placed inside the patient’s body. These are critical in emergency medicine to save lives.

Report Scope:

Market Dynamics

Growing prevalence of cardiovascular diseases and increasing incidences of sudden cardiac arrests globally

The increased prevalence of cardiovascular disorders and sudden cardiac arrest, together with the growing demand for effective emergency healthcare devices such as defibrillators, has surprisingly contributed to the expansion of the defibrillator market. Chronic diseases, particularly cardiovascular diseases, are among the leading causes of death worldwide, with the World Health Organization predicting a 31% global mortality rate from CVD. A true heart attack, which frequently comes without warning, needs on-the-spot defibrillation to restore a regular heartbeat and avert death.

This emerging healthcare issue drives the Defibrillator Market as technology and awareness progress the market’s growth cycle. Defibrillators are being placed in public buildings, office complexes, gyms, and other sports facilities since early post-cardiac arrest use of defibrillators can raise the survival rates to between 60 and 70%. Legal requirements and healthcare activities like the 2007 European regulation that restrained accessibility of AEDs to the public have been enhancing the use of these devices. Parameters like expenditure on healthcare, regional preferences, and costs and their impact on the market also affect the Defibrillator Market.

Rising public awareness and widespread CPR and defibrillator training programs in schools and workplaces

Citizen participation and increased CPR and automated external defibrillator (AED) training sessions in schools and workplaces significantly contribute to higher SCA survival outcomes. Over time, cardiovascular diseases and sudden cardiac arrests remain prominent causes of death, hence the need to intervene early. CPR and defibrillation can increase the patient’s survival rate if given promptly after the arrest. This focus on training programs is caused by the increasing awareness of the fact that a well-prepared public is capable of reacting effectively in emergencies and may help prevent deaths before the arrival of EMS personnel. Currently, the implementation of these life-saving programs is occurring mostly in schools, workplaces, and public places.

As more people get trained in both skills, the Defibrillator Market is also growing, owing to the increased demand for such devices in these sectors. Moreover, current mandates in many countries demand the presence of AEDs in schools, offices, and other public facilities, which serve as an added driver for the market. Increased education, availability of automated external defibrillators, and growth in access to facilities such as schools are expected to influence positive changes in the percentage of people who may benefit from defibrillators when suffering from sudden cardiac arrest across the world.

High defibrillator costs limit access, particularly in lower-income regions and smaller healthcare facilities

The main drawback of the defibrillator market is the high cost, which remains unaffordable for many regions, particularly low- and middle-income countries (LMICs) and small hospitals. Although automated external defibrillators (AEDs) are essential tools for saving lives after a sudden cardiac arrest (SCA), their prices and ongoing maintenance expenses are often prohibitively high. As a result, many hospitals, clinics, and emergency services in developing countries struggle to access these critical devices. This economic challenge is more so observable in developing nations where the aspect of health expenditures may be constrained and the concern may shift to more urgent exigencies than the funding of critical lifesaving technologies such as the AEDs.

Rural hospitals and clinics, and other small healthcare organizations, struggle to obtain these devices because of financial constraints. Therefore, there is a tendency for the death toll from sudden cardiac arrest to be high due to a deficiency of AEDs in such areas. The Defibrillator Market has recently seen more efforts to tackle this issue through government subsidies, non-profit organizations, and companies, as well as more affordable and easy-to-use models. Trying to minimize spending and making the service more available is the first step that can help to enhance global survival rates in cases of cardiac arrest.

Expanding healthcare infrastructure in emerging markets drives demand for defibrillators in medical facilities

Middle Eastern countries continue to invest in the structure of their separate healthcare systems, increasing demand for high-level medical equipment and accessories such as defibrillators. The rise of extramural cardiac arrests in these areas, as well as other non-traumatic cardiovascular disorders, has prompted concerns about the availability of AEDs in hospitals, clinics, and other emergency facilities.

Current initiatives of governments and other healthcare agencies involve improving healthcare delivery, which includes increasing the availability of critical facilities such as defibrillators. The development of modern medical facilities, such as specialist cardiac care facilities and emergency medical service (EMS) institutions, is driving market expansion. Furthermore, increased awareness of the importance of early defibrillation and CPR is driving the installation of automatic external defibrillators (AEDs) in public and smaller hospitals alike. Emerging markets continue to be attractive investment opportunities in healthcare. As a result, the Defibrillator Market needs to expand to accommodate shock delivery in both urban and rural areas.

Growth of public access defibrillation programs offering widespread defibrillator availability in public spaces

Increased acceptance of PAD programs is rapidly boosting the availability of automated external defibrillators, resulting in significant differences in outcomes after SCA. PAD programs are designed to deploy AEDs in locations where people live, work, and visit regularly, such as airports, malls, sports facilities, schools, and businesses. These programs are garnering more attention as part of larger efforts to improve emergency response skills and boost public knowledge of CVDs and the lifesaving chances that first response defibrillation provides.

The Defibrillator Market is expanding as ministries of health and other healthcare providers, along with non-governmental health groups, promote the use of automated external defibrillators and their deployment in society. This has resulted in increased spending on equipment such as defibrillators and emergency medical services frameworks, which is pushing innovations in the defibrillator market. Increased understanding of AEDs and CPR has also been an important aspect of these programs in public education.

Industry Experts Opinion

“If someone’s already survived a cardiac arrest or heart attack, they may get a defibrillator to protect them from a future event, there have recently been prominent examples in professional sports, where an athlete collapses from cardiac arrest and subsequently receives an ICD. In some cases, they can continue to play at a professional level.”

• Dr. Nathaniel Steiger, MD, Cardiac Electrophysiologist

Segment Analysis

Based on the Product Type, the Defibrillator Market has been classified into Implantable Cardioverter Defibrillators and External Defibrillators. ICDs are the major product types sold within the defibrillator market. Because ICDEDs provide steady monitoring plus treatment of deadly heart arrhythmias through shock delivery, they are the preferred choice of healthcare providers. These devices provide essential protection against sudden cardiac arrest for people at high risk. These devices lead the market because their advanced technology combined with proven long-term success and enhanced patient survival outcomes makes them the preferred choice. More patients requiring cardiovascular disease treatment and more clinical facilities using ICDs maintain the dominant position of defibrillators in this market.

Based on the Application, the Defibrillator market is further classified as Sudden Cardiac Arrest, Arrhythmia Management, and Congestive Heart Failure. Sudden Cardiac Arrest (SCA) is the dominant application, with the majority of defibrillators, particularly AEDs, installed for immediate response to SCA. The increasing occurrence of cardiac events in public spaces, along with the urgent need for quick defibrillation, is the primary factor driving market growth. The rising prevalence of cardiovascular incidences in public places and the exigency of immediate shocks to patients' hearts are the key trends in the market. Furthermore, the increasing role of defibrillators in the treatment of arrhythmias reveals an increasing implantable and wearable devices’ tendency. An increasing prevalence of patients suffering from congestive heart failure increases the use of defibrillators in chronic care, which will also boost market development.

Regional Analysis

The North American Defibrillator Market is leading due to the high incidence of cardiovascular diseases, an increase in life expectancy, and the availability of an advanced system of healthcare. The United States is most advanced in the adoption of automatic external defibrillators (AEDs) because of heightened awareness of SCA and the development of PAD initiatives in schools, airports, and the workplace. Market growth has also been boosted by factors such as regulatory support, including the need for AEDs on public premises. Moreover, several leading medical device manufacturing companies, including Medtronic, Philips, and Zoll, have leading positions in the region, which in turn helps the development and availability of products. The market in North America is also characterized by healthcare reimbursement policies and high healthcare expenditure.

The Asia-Pacific Defibrillator Market is expanding owing to the increasing incidence of cardiovascular diseases and heightened awareness of sudden cardiac arrest (SCA). China, India, Japan, and South Korea are some of the largest consumers of defibrillators, as they are investing significantly in their healthcare systems, and there is an increasing emphasis on placing these devices in public places. With emergency response systems being a major focus, initiatives to increase the deployment of AEDs are on the rise, particularly in areas of high population density. PAD programs are being encouraged by governments and healthcare institutions to improve the chances of survival. These factors, combined with the growing middle-class residents and increasing healthcare expenditures, are driving the market in the region. However, barriers like cost and availability in rural settings remain a concern.

Competitive Landscape

The Defibrillator Market is growing at a substantial rate due to factors like rising cases of cardiovascular diseases, awareness about the products, and technological developments. Some of the most significant companies and manufacturers in the market include Medtronic, Philips Healthcare, Zoll Medical Corporation, Boston Scientific, and Physio-Control, which is now a part of Stryker. Recently, Medtronic has announced the enhancements and new additions to the product portfolio of defibrillators. Philips Healthcare is not only developing newer AEDs but is consistently working to incorporate features that allow for greater ease of operation, including output monitoring and data analytics. Zoll Medical has strived to develop advanced AED technology, offering devices with better mobility and functionality. At the same time, Boston Scientific has been developing subcutaneous ICD therapy, giving patients more efficient treatment modalities. They are also continuing to fund their research for new products that will meet the growing market needs for vital life-saving devices and better the lives of patients worldwide.

Defibrillator Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, Kestra Medical Technologies, Inc. announced an oversubscribed $196 million funding round to support the expansion of its commercial organization and advance its mission of protecting at-risk patients with its modern Wearable Cardioverter Defibrillator (WCD.
• In June 2024, Stryker, a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive, modern platform to help advance patient care.

Report Coverage:

By Product Type

• Implantable Cardioverter Defibrillators

• Single-chamber ICDs
• Dual-chamber ICDs
• Subcutaneous ICDs

• External Defibrillators

• Manual External Defibrillators
• Automated External Defibrillators
• Wearable Cardioverter Defibrillators

By Application

• Sudden Cardiac Arrest
• Arrhythmia Management
• Congestive Heart Failure

By Distribution Channel

• Direct Sales
• Retail Pharmacies
• Online Sales

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Public Access Settings
• Emergency Medical Services

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Philips Healthcare
• Medtronic
• Zoll Medical Corporation
• Cardiac Science
• Stryker Corporation
• Abbott Laboratories
• Nihon Kohden Corporation
• Boston Scientific
• Welch Allyn
• Physio-Control
• Schiller AG
• LivaNova
• Mindray Medical International Limited
• Asahi Kasei Corporation
• Roche Diagnostics

 

Frequently Asked Questions (FAQs)